المؤلفون: María Sanjurjo-Sáez, Andrés Muñoz, Eva González-Haba, Lucia Cortejoso-Fernandez, Luis A. López-Fernández, Miguel Martín, Maria-Isabel Garcia-Garcia, Montse Blanco Codeisido, Pilar Alfonso, Daniel Lopez-Trabada Ataz

المصدر: Journal of Clinical Oncology. 31:390-390

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Colorectal cancer, medicine.disease, Oxaliplatin, Capecitabine, FOLFOX, Methylenetetrahydrofolate reductase, Internal medicine, biology.protein, Medicine, DPYD, ERCC1, business, Pharmacogenetics, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c1e7d05554d82d5e5603309907f4a584
https://doi.org/10.1200/jco.2013.31.4_suppl.390